CRF1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

摘要

CRF ₁ receptor antagonists have the potential to normalize androgen production by directly inhibiting ACTH release in CAH patients while using lower, more physiological doses of hydrocortisone, thereby reducing treatment-related side effects.